S-adenosylmethionine treatment diminishes the proliferation of castration-resistant prostate cancer cells by modulating the expression of miRNAs

AdoMet (S-adenosylmethionine) inhibits cancer cell proliferation and migration via epigenetic alterations. This study aimed to investigate whether AdoMet may cause alterations in microRNA (miRNA) expression profiles that are important for the initiation and progression of prostate cancer. PC-3 cells...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Schmidt, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 November 2024
In: Archivum immunologiae et therapiae experimentalis
Year: 2024, Jahrgang: 72, Heft: 1, Pages: 1-50
ISSN:1661-4917
DOI:10.2478/aite-2024-0022
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.2478/aite-2024-0022
Volltext
Verfasserangaben:Thomas Schmidt

MARC

LEADER 00000caa a2200000 c 4500
001 1921685409
003 DE-627
005 20250717005056.0
007 cr uuu---uuuuu
008 250407s2024 xx |||||o 00| ||eng c
024 7 |a 10.2478/aite-2024-0022  |2 doi 
035 |a (DE-627)1921685409 
035 |a (DE-599)KXP1921685409 
035 |a (OCoLC)1528044138 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schmidt, Thomas  |e VerfasserIn  |0 (DE-588)1318433886  |0 (DE-627)1880033798  |4 aut 
245 1 0 |a S-adenosylmethionine treatment diminishes the proliferation of castration-resistant prostate cancer cells by modulating the expression of miRNAs  |c Thomas Schmidt 
264 1 |c 1 November 2024 
300 |b Illustrationen 
300 |a 50 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.04.2025 
520 |a AdoMet (S-adenosylmethionine) inhibits cancer cell proliferation and migration via epigenetic alterations. This study aimed to investigate whether AdoMet may cause alterations in microRNA (miRNA) expression profiles that are important for the initiation and progression of prostate cancer. PC-3 cells were treated with AdoMet before miRNA sequencing. A total of 17 differentially expressed miRNAs were detected. Target gene prediction was performed by means of databases. Results were aligned to transcriptomic data. The bioinformatic analysis revealed upregulation of anticancerogenic genes, downregulation of cancerogenic-related processes and pathways. Knocking down hsa-miR-192-5p in PC-3 cells resulted in downregulation of cancer cell proliferation, thus confirming these results. 
650 4 |a Ado-Met 
650 4 |a Cell Line, Tumor 
650 4 |a Cell Movement 
650 4 |a Cell Proliferation 
650 4 |a Computational Biology 
650 4 |a Epigenesis, Genetic 
650 4 |a Gene Expression Profiling 
650 4 |a Gene Expression Regulation, Neoplastic 
650 4 |a Humans 
650 4 |a Male 
650 4 |a MicroRNAs 
650 4 |a miRNAs 
650 4 |a PC-3 cells 
650 4 |a PC-3 Cells 
650 4 |a Prostatic Neoplasms, Castration-Resistant 
650 4 |a S-Adenosylmethionine 
650 4 |a TGF-beta pathway 
773 0 8 |i Enthalten in  |t Archivum immunologiae et therapiae experimentalis  |d Warsaw, Poland : Sciendo, 1994  |g 72(2024), 1, Seite 1-50  |h Online-Ressource  |w (DE-627)389872318  |w (DE-600)2149971-8  |w (DE-576)281253188  |x 1661-4917  |7 nnas  |a S-adenosylmethionine treatment diminishes the proliferation of castration-resistant prostate cancer cells by modulating the expression of miRNAs 
773 1 8 |g volume:72  |g year:2024  |g number:1  |g pages:1-50  |g extent:50  |a S-adenosylmethionine treatment diminishes the proliferation of castration-resistant prostate cancer cells by modulating the expression of miRNAs 
856 4 0 |u https://doi.org/10.2478/aite-2024-0022  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250407 
993 |a Article 
994 |a 2024 
998 |g 1318433886  |a Schmidt, Thomas  |m 1318433886:Schmidt, Thomas  |d 60000  |d 65000  |e 60000PS1318433886  |e 65000PS1318433886  |k 0/60000/  |k 1/60000/65000/  |p 1  |x j  |y j 
999 |a KXP-PPN1921685409  |e 4697905644 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"noteIll":"Illustrationen","extent":"50 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2149971-8"],"eki":["389872318"],"issn":["1661-4917"]},"origin":[{"publisherPlace":"Warsaw, Poland ; Boston, MA ; Wrocław ; Basel ; Basel ; [Cham (ZG)]","publisher":"Sciendo ; IITD PAN ; Birkhäuser ; Springer ; [Springer International Publishing AG]","dateIssuedKey":"2024","dateIssuedDisp":"2024-"}],"name":{"displayForm":["Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław"]},"part":{"extent":"50","text":"72(2024), 1, Seite 1-50","volume":"72","issue":"1","pages":"1-50","year":"2024"},"titleAlt":[{"title":"AITE"}],"pubHistory":["Nachgewiesen 42.1994 -"],"recId":"389872318","corporate":[{"display":"Instytut Immunologii i Terapii Doświadczalnej Imienia Ludwika Hirszfelda","roleDisplay":"Herausgebendes Organ","role":"isb"}],"language":["eng"],"disp":"S-adenosylmethionine treatment diminishes the proliferation of castration-resistant prostate cancer cells by modulating the expression of miRNAsArchivum immunologiae et therapiae experimentalis","note":["Gesehen am 27.03.24","Frühere Jg. online nicht mehr verfügbar"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"Archivum immunologiae et therapiae experimentalis","title":"Archivum immunologiae et therapiae experimentalis","subtitle":"AITE"}]}],"name":{"displayForm":["Thomas Schmidt"]},"origin":[{"dateIssuedDisp":"1 November 2024","dateIssuedKey":"2024"}],"id":{"eki":["1921685409"],"doi":["10.2478/aite-2024-0022"]},"note":["Gesehen am 07.04.2025"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1921685409","person":[{"family":"Schmidt","given":"Thomas","roleDisplay":"VerfasserIn","display":"Schmidt, Thomas","role":"aut"}],"title":[{"title_sort":"S-adenosylmethionine treatment diminishes the proliferation of castration-resistant prostate cancer cells by modulating the expression of miRNAs","title":"S-adenosylmethionine treatment diminishes the proliferation of castration-resistant prostate cancer cells by modulating the expression of miRNAs"}]} 
SRT |a SCHMIDTTHOSADENOSYLM1202